Peter Shabe - Biostatistics

Peter Shabe, MS, has over twenty years of experience with clinical trials. This experience spans such broad therapeutic areas as recombinant biologics used in cancer and infectious disease, analgesics, dematologics, birth control products, over-the-counter pain relievers, and particularly extensive work in the field of medical devices. His career roles have included managing large clinical data management and biostatistics operations for both pharmaceutical companies and contract research organisations.

Pete earned his undergraduate degree in computational science with a minor in psychology, followed by a masters in statistics from Marquette University in Milwaukee, Wisconsin. He joined the clinical research industry in 1985 as a bio-statistician for Syntax Laboratories. In the ensuing years, he has held positions of increasing responsibility with Cetus Corporation, Collagen Corporation, Parexel, and Resource Biometrics. In 1996, Pete founded his own company, Advance Research Associates where he manages a team of biostatisticians and data management professionals for Emissary's clients worldwide.

Adidas footwear実は結構ヤバい!恋愛依存症の女性の特徴5選

Sarah Lenington - Clinical Operations

Sarah Lenington, Ph.D, earned her undergraduate in mathematics and philosophy with Magna cum Laude honors and then completed 3 years of medical school at the University of Minnesota. Deciding to pursue a career in academia instead, Sarah next obtained a doctorate in biology from the University of Chicago and a post-doctoral fellowship in cancer epidemiology at the University of Illinois. She then took a faculty position at Rutgers University, rising quickly to become an Associate Professior in the Institute of Animal Behavior.

In the 1990's, Sarah gained invaluable international experience, initially working in genetics research at The Hebrew University in Jerusalem before entering the medical device industry. Working as an applications specialist for a emerging company in the field of breast cancer detection, Sarah travelled extensively to China, Korea, North America, Latin America and across Europe liaising with world-renowned cancer researchers and breast cancer specialists. In this role, Sarah was integral in negotiating a deal with Siemens to co-market this technology, which then lead to a position directly with Siemens and has published extensively in the fields of cancer, genetics, biology, and animal science.

In 2002, Sarah moved back to the United States to serve as the worldwide director of clinical development for a medical device company. In this role, she designed study protocols, managed a staff of clinical research associates, and undertook the statistical analysis and medical writing task for a major PMA application. Sarah is named in the patent for this breast cancer detection technology and authored all the regulatory submissions.

After taking this company thru the PMA process, including making presentations to the FDA, Sarah joined the team at Emissary, which had been the CRO assisting her innovative company. In her role with Emissary, Sarah continues to manage clinical trials, direct clinical research associates, recruit clinical trial sites, and undertakes various medical writing and clinical data analysis tasks for Emissary clients internationally.

Sportswear DesignAir Jordan 1 Retro High OG Wmns "Panda" CD0461-007 Women/Men Super Deals, Price: $98.03 - Air Jordan Shoes

Steven Mayo - Emissary's CEO

Steven W. Mayo, PD, CCRA, PMP is the founder and president of Emissary International, LLC, a contract research organization providing clinical trial management services in North America and Europe. Steve holds a Doctor of Pharmacy degree and subsequently trained as an MBA. He is a Certified Clinical Research Associate (CCRA) from the Association of Clinical Research Professionals and also is certified as a Project Management Professional (PMP) by the Project Management Institute.

latest Nike release2021年注目!おしゃれメンズも夢中のネクストブレイク必至スニーカー10選

Read more: Steven Mayo - Emissary's CEO